Clinical Trial Update: Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia [Phase 3]

View source ↗

Summary

Phase 3 trial update for Gardasil-9 after local conservative treatment of cervical intraepithelial neoplasia has completed. The study status indicates completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• GARDASIL9 (HPV vaccine, nonavalent (types 6, 11, 16, 18, 31, 33, 45, 52, 58))

Snippet

Sponsor: Imperial College London | Conditions: Neoplasia | Phase 3 | Status: COMPLETED